Skip to main content
. 2004 Mar 16;90(8):1502–1507. doi: 10.1038/sj.bjc.6601713

Table 3. Toxicity per patient (WHO grades) during the whole trial.

Toxicity Per patient (89)
Per cycle (487)
  Grade 1–2 Grade 3 Grade 4 Grade 1–2 Grade 3 Grade 4
Anaemia 24 (27%) 5 (6%)   60 (12%) 7 (1%)  
Thrombocytopenia 3 (3%)     3 (1%)    
Nausea/vomiting 59 (66%) 3 (3%) 1 (1%) 184 (38%) 10 (2%) 3 (1%)
Diarrhoea 32 (36%) 10 (11%) 3 (3%) 94 (19%) 7 (1%) 6 (1%)
Stomatitis 6 (7%) 2 (2%)   8 (2%) 2 (1%)  
Transaminases 26 (29%) 4 (4%) 2 (2%) 73 (15%) 7 (1%) 2 (1%)
Asthenia 27 (30%) 3 (3%)   109 (22%) 3 (1%)  
Alopecia 31 (35%) 6 (7%) 3 (3%) 99 (20%) 14 (3%) 16 (3%)
Cholinergic syndrome 20 (22%)     44 (9%)